Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2005-03-01 | DR. IRIT ARBEL joined the Company in April 2004 as a director and as our President and Chief Executive Officer and held such position until she resigned in November 2004 in order to enable Dr. Beck's appointment. Dr. Arbel was President and CEO of Pluristem Life Systems, Inc. from 2003 to June 2004, and was Israeli Sales Manager of Merck, Sharp & Dohme from 1998 to 2002. From 1995 to 1997, Dr. Arbel served as the head of research for Hadassa-Ein Karem Hospital in Jerusalem. |
| 2006-11-20 | Irit Arbel Consists of (i) 2,300,000 shares of Common Stock owned by Dr. Arbel; and (ii) 133,333 shares of Common Stock issuable upon the exercise of Presently Exercisable Options at an exercise price of $0.15. |
| 2008-04-29 | Dr. Arbel also holds a Chemical Engineering degree from the Technion, Israel's Institute of Technology. |
Data sourced from SEC filings. Last updated: 2026-02-03